Norstella Formed by Uniting Evaluate, MMIT, Panalgo and The Dedham Group
May 3, 2022
Four life‑sciences solutions providers — Evaluate, MMIT, Panalgo and The Dedham Group — have united under the new organization Norstella to combine data, analytics, software and market‑access consulting to speed patient access to therapies. The move creates an integrated platform offering commercial intelligence, market access insights and healthcare analytics to pharmaceutical manufacturers and other life‑sciences customers.
- Buyers
- Norstella
- Targets
- Evaluate, MMIT (Managed Markets Insight & Technology), Panalgo, The Dedham Group
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Norstella and Citeline Merge to Create $5B Global Pharma Technology Company
June 28, 2022
Data & Analytics
Norstella (the group of Evaluate, MMIT, Panalgo and The Dedham Group) announced an agreement to merge with Citeline (formerly Pharma Intelligence) to form a combined global pharmaceutical technology and intelligence business valued at about $5 billion. The combination brings clinical trial intelligence, commercial data and real‑world analytics together to offer an end‑to‑end suite of solutions for life sciences companies; the deal involves financial sponsors including Hg (Norstella) and Warburg Pincus (Citeline).
-
MMIT/Evaluate Acquires Panalgo to Enhance Pharma Analytics Platform
September 28, 2021
Data & Analytics
Managed Markets Insight & Technology (MMIT) and Evaluate (a WCAS and Hg portfolio company) have acquired Panalgo, a healthcare data analytics firm, and will integrate Panalgo's Instant Health Data (IHD) software into the combined MMIT/Evaluate commercialization platform. The acquisition aims to accelerate real-world evidence and market-access analytics capabilities for biopharma, medical device and CRO customers; Silversmith Capital Partners and Transformation Capital (prior Panalgo investors) will remain investors in the combined company.
-
Welsh, Carson, Anderson & Stowe and Hg Combine MMIT and Evaluate to Form Global Pharma Commercial Intelligence Provider
August 20, 2021
Data & Analytics
Welsh, Carson, Anderson & Stowe (WCAS) and Hg have combined Yardley, Pennsylvania-based MMIT and London-based Evaluate into a single, PE-controlled pharmaceutical commercial intelligence business. The merger brings together MMIT’s market-access data and Evaluate’s forecasting and commercial analytics to create a $1.6 billion global provider offering end-to-end insights across the drug life cycle; WCAS and Hg will share joint control of the combined company.
-
Cornell Capital and Trilantic North America Acquire trustaff and CardioSolution and Agree to Acquire Stella to Create Tech-Enabled Healthcare Staffing Platform
February 8, 2021
Healthcare Services
Cornell Capital LLC and Trilantic North America have acquired trustaff Management, Inc. and CardioSolution and agreed to acquire Stella.ai, combining the three companies into a technology-enabled healthcare staffing platform. The PE sponsors plan to accelerate growth through data science, automation and management-led expansion while retaining key management and board participation.
-
Gridiron Capital and Stella Point Capital Merge Portfolio Companies TNAA and TotalMed
May 29, 2025
Healthcare Services
Gridiron Capital and Stella Point Capital have closed a strategic merger combining Gridiron's portfolio company Travel Nurse Across America (TNAA) and Stella Point's portfolio company TotalMed to create a larger, tech-enabled healthcare staffing and MSP provider. The combined company will offer expanded travel nursing, MSP/VMS workforce solutions, shift-fulfillment technology, locum tenens, life sciences staffing and related services to hospitals, health plans and life sciences clients across the United States.
-
Thoma Bravo and Madison Dearborn Partners Complete Investments in Syntellis Performance Solutions
August 3, 2020
Software
Funds affiliated with private equity firms Thoma Bravo and Madison Dearborn Partners completed investments in Syntellis Performance Solutions, enabling the company to operate as a standalone, software-focused business. The transaction provides capital and resources to accelerate product innovation, expand client services, and support growth across healthcare, higher education and financial institution markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.